Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism

Journal of Interventional Cardiology

Volumn 18, Issue 3, 2005, Pages 173-179

  Chatterjee, Tushar ^a   Petzsch, Michael ^a   Ince, Hüseyin ^a   Rehders, Tim C ^a   Körber, Thomas ^a   Weber, Frank ^a   Schneider, Henrik ^a   Auf Der Maur, Christoph ^b   Nienaber, Christoph A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b Division of Cardiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD EXAMINATION; BRAIN EMBOLISM; BRAIN ISCHEMIA; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DEVICE; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART TAMPONADE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARADOXICAL EMBOLISM; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 21744445993     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.04050.x     Document Type: Article

References (36)

1. Webster MWI, Chancellor AM. Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
2. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
3. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Neurology 1996;46:1301-1305.
4. Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
5. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factor for cryptogenic stroke in patients less than 55 years of age; A study using transoesophageal echocardtography. Stroke 1993;24:1865-1873.
6. Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
7. Hart RG, Miller VT. Cerebral infarction in young adults: A practical approach. Stroke 1983; 14:110-114.
8. Kessel-Schaefer A, Lefkovits M, Zellweger MJ, et al. Migrating thrombus trapped in a patent foramen ovale. Circulation 2001;103:1928
9. Hanna JP, Sun JP, Furlan AJ, et al. Patent foramen ovale and brain infarct. Echocardiagraphic predictors, recurrence and prevention. Stroke 1994;25:782-786.
10. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
11. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
12. Curec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999;15:57-64.
13. Nendaz MR, Sarasin FP, Junod AF, et al. Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective. Am Heart J 1998;135:532-541.
14. Devuyst G, Bogousslavsky J, Ruchad P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transoesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-1166.
15. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-2381.
16. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:III71-II175.
17. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
18. Hung J, Landzberg MJ, Jenskins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
19. Du ZD, Cao QL, Joseph A, et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: Intermediate-term risk of recurrent neurological events. Cardiovasc Intervent 2002;55:189-194.
20. Chatterjee T, Aeschbacher BC, Meier B. Ischemic attacks and patent foramen ovale: Transcatheter closure of patent foramen ovale in adults with cryptogenic systemic embolism. J Interven Cardiol 1999;12:59-64.
21. Sharafuddin MJA, Gu X, Titus JL, et al. Transvenous closure of secundum atrial septal defects: Preliminary results with a new self-expanding Nitinol prosthesis in a swine model. Circulation 1997;95:2162-2168.
22. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;96:358-366.
23. Cohnheim J. Thrombose und Embolie. Vorlesung über Allgemeine Pathologie. Bd 1. Berlin: Hirschwald, 1877,175-176.
24. Corrin B. Paradoxical embolism. Br Heart J 1964;26:549-553.
25. Nelson CW, Snow FR, Bamett M, et al. Impending paradoxical embolism: Echocardiographic diagnosis of an intracardiac thrombus crossing a patent foramen ovale. Am Heart J 1991;22:859-862.
26. Sacco RL, Ellenberg JH, Mohr JP, et al, Infarcts of undetermined cause: The NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
27. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
28. Fox ER, Picard MH, Chow CM, et al. Interatrial septal mobility predicts larger shunts across patent foramen ovales: An analysis with transmitral Doppler scanning. Am Heart J 2003;145:730-736.
29. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: Clinical epidemiology, prediction and prevention. Am J Med 1993;95:315-328.
30. Levine MN, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108:276-290.
31. Harvey JR, Teague SM, Anderson JL, et al. Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Int Med 1986;105:695-697.
32. Zhu WX, Khanderia BK, Warnes CA. Closure of patent foramen ovale for crytogenic stroke in young patients: Long-term follow-up. Circulation 1992;86:I-147.
33. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
34. Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-1413.
35. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Single center experience. Circulation 2002;105:2845-2848.
36. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interven Cardiol 2003;16:43-50.